<?xml version="1.0" encoding="UTF-8"?>
<p>In a survey of 269 female patients with breast cancer in Israel, 111 (41.3%) reported using herbal medicinal products for cancer-related goals. Among the entire cohort, 29.4% expected the integrative physician to provide guidance on the use of herbal medicine for cancer-related outcomes, with 48.6% of those using herbal medicine expressing this expectation (vs. 14.8% of nonusers; 
 <italic>p</italic> &lt; 0.001). The integrative physician recommended that 17 patients (15.3%) stop taking specific herbal products, because of potentially toxic effects and/or negative interactions with conventional drugs. At the same time, 10 patients in the entire cohort (3.7%) were advised to add a dietary/herbal supplement to their regimen, with the goal of reducing chemotherapy-related toxicities [
 <xref rid="B69-pharmaceuticals-13-00455" ref-type="bibr">69</xref>].
</p>
